Highlights of the American and Canadian Academies of Child and Adolescent Psychiatry 2005 Joint Annual Meeting
23rd Nov 2005, 22:42 GMT
Learn new findings about manifestations of ADHD from childhood through adulthood, along with the influence of comorbidities on diagnosis and treatment. (CME,CE)
Highlights of the American and Canadian Academies of Child and Adolescent Psychiatry 2005 Joint Annual Meeting related news:
- American and Canadian Academies of Child and Adolescent Psychiatry 2005 Joint Annual Meeting — Medscape Neurology Headlines
- Livers Under Wrap: ASLD 2005 — MedPage Today Gastroenterology
- Livers Under Wrap: AASLD 2005 — MedPage Today Infectious Disease
- Callisto Anti-Cancer Drug Atiprimod Selected for Oral Presentation at Annual Meeting of American Society of Hematology — Pharmaceuticals News from StratCenter.com
- TheraVitae to Present Blood-borne Stem Cell Research Innovations at the 47th Annual Meeting of the American Society of Hematology — PR Web - Breaking News Stories
- Distinguishing Between ADHD and Bipolar Disorder — Medscape Psychiatry Headlines
- Carey Wins One of Four at the AMAs — TheCelebrityCafe.com Magazine
- Alabama Farmers Federation annual meeting set for Mobile — Latest news from Birmingham Business Journal
- Siemens Medical Solutions is Setting the Trend Again at RSNA 2005; Siemens Highlights Leadership in Molecular Medicine, Information Technology and Dual Source CT Imaging at World's Largest Medical Meeting — RedOrbit News - Health
- Destiny's Child member Kelly Rowlands accepts the award for ... — Entertainment Photos - AP on Yahoo! News Photos
Latest news from Medscape Neurology Headlines:
- Transparent Measures Are Essential for Coordinating and Rewarding Quality Improvement in Healthcare
- Improving Caregiver Well-being Delays Nursing Home Placement of AD Patients
- New Guideline Helps Diagnose Pediatric Status Epilepticus
- SALT 1 and 2: Tolvaptan Shows Promise in Hyponatremia
- Cognition Impaired After Bypass Surgery in Smokers
- Recognizing and Managing Stimulant Complications
- FDA Safety Changes: Prevacid NapraPAC, Epzicom, Forane
- Oral Inhalation of Apomorphine May Relieve "Off" Periods in PD
- Creatine, Minocycline May Warrant Further Study in PD
- DEFUSE Study: MRI Predicts Ischemic Stroke Outcomes